Safety and efficacy of standard of care ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM): real world experience
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
关键词
relapsed/refractory multiple myeloma,multiple myeloma,care ciltacabtagene,rrmm,cilta-cel
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要